Apollo Endosurgery, Inc.
DelistedCIK 1251769fmd_1S480YDQBK7S5AGVEY1CC58FH7Manufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Jan 01, 2010 to Dec 31, 2022, 51 periods
Latest annual · FY2022
Millions- Total revenues
- 77
- Gross profit
- 42
- Operating income
- (31)
- Net income
- (40)
- Free cash flow
- (34)
Latest quarter · Q4 FY2022
Millions- Total revenues
- 21
- Gross profit
- 11
- Operating income
- (11)
- Net income
- (10)
- Free cash flow
- (11)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2019 to FY2022
- +14.9%
- Revenue, 5 yearsFY2017 to FY2022
- +3.6%
- Net income, 5 yearsFY2017 to FY2022
- n/m
Apollo Endosurgery, Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2022 | FY2021 | Change | Source |
|---|---|---|---|---|
| Revenue | $76.9 million | $63 million | +22% | 10-K 2023-03-30 · proof |
| Gross profit | $42.4 million | $35 million | +21.4% | 10-K 2023-03-30 · proof |
| Operating income | -$31.4 million | -$19.2 million | 10-K 2023-03-30 · proof | |
| Net income | -$39.8 million | -$24.7 million | 10-K 2023-03-30 · proof | |
| Cash from operating activities | -$31.3 million | -$14.5 million | 10-K 2023-03-30 · proof | |
| Free cash flow | -$33.5 million | -$15.6 million | 10-K 2023-03-30 · proof | |
| Total assets | $110.2 million | $131.5 million | -16.2% | 10-K 2023-03-30 · proof |
| Total liabilities | $77.6 million | $70.3 million | +10.5% | 10-K 2023-03-30 · proof |
| Cash and cash equivalents | $57 million | $90.7 million | -37.1% | 10-K 2023-03-30 · proof |
- What was Apollo Endosurgery, Inc.'s revenue in fiscal 2022?
- Apollo Endosurgery, Inc. reported revenue of $76.9 million for fiscal 2022 (the year ended Dec 31, 2022), against $63 million the year before (+22%). Source: the 10-K filed with the SEC on Mar 30, 2023. SEC
- What was Apollo Endosurgery, Inc.'s gross profit in fiscal 2022?
- Apollo Endosurgery, Inc. reported gross profit of $42.4 million for fiscal 2022 (the year ended Dec 31, 2022), against $35 million the year before (+21.4%). Source: the 10-K filed with the SEC on Mar 30, 2023. SEC
- What was Apollo Endosurgery, Inc.'s operating income in fiscal 2022?
- Apollo Endosurgery, Inc. reported operating income of -$31.4 million for fiscal 2022 (the year ended Dec 31, 2022), against -$19.2 million the year before. Source: the 10-K filed with the SEC on Mar 30, 2023. SEC
- What was Apollo Endosurgery, Inc.'s net income in fiscal 2022?
- Apollo Endosurgery, Inc. reported net income of -$39.8 million for fiscal 2022 (the year ended Dec 31, 2022), against -$24.7 million the year before. Source: the 10-K filed with the SEC on Mar 30, 2023. SEC
- What was Apollo Endosurgery, Inc.'s cash from operating activities in fiscal 2022?
- Apollo Endosurgery, Inc. reported cash from operating activities of -$31.3 million for fiscal 2022 (the year ended Dec 31, 2022), against -$14.5 million the year before. Source: the 10-K filed with the SEC on Mar 30, 2023. SEC
- What was Apollo Endosurgery, Inc.'s free cash flow in fiscal 2022?
- Apollo Endosurgery, Inc. reported free cash flow of -$33.5 million for fiscal 2022 (the year ended Dec 31, 2022), against -$15.6 million the year before. Source: the 10-K filed with the SEC on Mar 30, 2023. SEC
- What are Apollo Endosurgery, Inc.'s total assets?
- As of Dec 31, 2022, Apollo Endosurgery, Inc. reported total assets of $110.2 million, against $131.5 million a year earlier (-16.2%). Source: the 10-K filed with the SEC on Mar 30, 2023. SEC
- What are Apollo Endosurgery, Inc.'s total liabilities?
- As of Dec 31, 2022, Apollo Endosurgery, Inc. reported total liabilities of $77.6 million, against $70.3 million a year earlier (+10.5%). Source: the 10-K filed with the SEC on Mar 30, 2023. SEC
- What are Apollo Endosurgery, Inc.'s cash and cash equivalents?
- As of Dec 31, 2022, Apollo Endosurgery, Inc. reported cash and cash equivalents of $57 million, against $90.7 million a year earlier (-37.1%). Source: the 10-K filed with the SEC on Mar 30, 2023. SEC
Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1251769&period_type=annual&limit=5"Information only, not investment advice.